Skip to content

CytoDyn to update investors on regulatory and clinical activities September 2

August 28, 2020

CytoDyn (OTCQB:CYDY) will host a conference call on Wednesday, September 2, at 4:00 pm ET to update investors on all of its regulatory and clinical initiatives including its activities related to leronlimab in COVID-19.

CEO Nader Pourhassan, Ph.D., Chairman, CMO and Head of Business Development Scott Kelly, M.D. and Chief Science Advisor Jacob Lalezari, M.D. will host.

Management will allocate ~45 minutes for Q&A.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: